Thus, we took western blot experiments to test the expression levels of PTEN, AKT, p‐AKT, GSK3β, p‐GSK3β, and cyclinD1 in the osteoblasts from ten myeloma patients. This evidence concerns the gene GSK3B and plasma cell myeloma.